|
Author(s):
|
Adrian J. Goldszmidt, MD, Director, Cerebrovascular Program, Sinai Hospital, Instructor of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland
Louis R. Caplan, MD, Director of Cerebrovascular Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, Professor of Neurology, Harvard Medical School, Boston, Massachusetts
|